05Feb 2021
Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly

Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly

Several observational studies have suggested that β-blockers, especially cardioselective ones, are well tolerated and associated with a lower risk of acute exacerbations and death in patients with chronic obstructive pulmonary disease (COPD). However, there are dissenting studies. This review provides an update on the use of β-blockers in COPD, focusing on results of recent prospective studies and randomized controlled trials.

  • #pulmonology

Like

Save

Share